Cholera-toxin suppresses carcinogenesis in a mouse model of inflammation-driven sporadic colon cancer

作者: Michael Doulberis , Katerina Angelopoulou , Eleni Kaldrymidou , Anastasia Tsingotjidou , Zaphiris Abas

DOI: 10.1093/CARCIN/BGU325

关键词: ColitisAzoxymethaneImmune systemColorectal cancerIntestinal mucosaBiologyCancerGut floraCarcinogenesisImmunology

摘要: Human studies and clues from animal models have provided important links between gastrointestinal (GI) tract bacteria colon cancer. Gut microbiota antigenic stimuli play an role in shaping the intestinal immune responses. Therefore, especially case of inflammation-associated cancer, gut antigens may affect tumorigenesis. The present study aimed to investigate effects oral administration a bacterial product with known immunomodulatory properties on inflammation-driven colorectal neoplasmatogenesis. For that, we used cholera-toxin well-established mouse model cancer which neoplasia is initiated by single dose genotoxic agent azoxymethane (AOM) subsequently promoted inflammation caused colitogenic substance dextran sodium sulfate (DSS). We found that single, low, non-pathogenic CT, given orally at beginning each DSS treatment cycle downregulated neutrophils upregulated regulatory T-cells IL-10 colonic mucosa. CT-induced disruption tumor-promoting character DSS-induced led reduction AOM-initiated polypoidogenesis. This result adds value emerging notion certain GI or their products system render microenvironment preneoplastic lesions less favorable for promoting evolution

参考文章(47)
Robert H. Riddell, Tumors of the intestines Armed Forces Institute of Pathology. ,(2003)
Jessica R. Lakritz, Theofilos Poutahidis, Tatiana Levkovich, Bernard J. Varian, Yassin M. Ibrahim, Antonis Chatzigiagkos, Sheyla Mirabal, Eric J. Alm, Susan E. Erdman, Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice International Journal of Cancer. ,vol. 135, pp. 529- 540 ,(2014) , 10.1002/IJC.28702
Ed C. Lavelle, Edel McNeela, Michelle E. Armstrong, Olive Leavy, Sarah C. Higgins, Kingston H. G. Mills, Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. Journal of Immunology. ,vol. 171, pp. 2384- 2392 ,(2003) , 10.4049/JIMMUNOL.171.5.2384
B. Levin, P. Boyle, World Cancer Report 2008 ,(2009)
Graham A. W. Rook, Angus Dalgleish, Infection, immunoregulation, and cancer Immunological Reviews. ,vol. 240, pp. 141- 159 ,(2011) , 10.1111/J.1600-065X.2010.00987.X
Jan Holmgren, Joaquín Sánchez, Cholera toxin — A foe & a friend Indian Journal of Medical Research. ,vol. 133, pp. 153- 163 ,(2011)
J.-B. Sun, C. Czerkinsky, J. Holmgren, Mucosally induced Immunological Tolerance, Regulatory T Cells and the Adjuvant Effect by Cholera Toxin B Subunit Scandinavian Journal of Immunology. ,vol. 71, pp. 1- 11 ,(2010) , 10.1111/J.1365-3083.2009.02321.X
Shao-Bo Su, Phyllis B. Silver, Peng Wang, Chi-Chao Chan, Rachel R. Caspi, Cholera Toxin Prevents Th1-Mediated Autoimmune Disease by Inducing Immune Deviation Journal of Immunology. ,vol. 173, pp. 755- 761 ,(2004) , 10.4049/JIMMUNOL.173.2.755
I. Bergerot, C. Ploix, J. Petersen, V. Moulin, C. Rask, N. Fabien, M. Lindblad, A. Mayer, C. Czerkinsky, J. Holmgren, C. Thivolet, A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 4610- 4614 ,(1997) , 10.1073/PNAS.94.9.4610
Theofilos Poutahidis, Markus Kleinewietfeld, Susan E. Erdman, Gut microbiota and the paradox of cancer immunotherapy. Frontiers in Immunology. ,vol. 5, pp. 157- 157 ,(2014) , 10.3389/FIMMU.2014.00157